Product image of Metotrexato Semanal Cipla (Methotrexate) supplied by GNH India

Metotrexato Semanal Cipla

Active Ingredient:
Methotrexate
Origin:
EU

Metotrexato Semanal Cipla (Methotrexate)

Methotrexate, the active ingredient in Metotrexato Semanal Cipla, is a folate antagonist antimetabolite presented as an oral tablet for weekly use. It is employed to modify disease progression in autoimmune disorders and certain malignancies. The medication belongs to the disease-modifying antirheumatic drug (DMARD) class and is indicated for conditions such as rheumatoid arthritis, severe psoriasis, acute lymphoblastic leukemia, and non‑Hodgkin lymphoma.

GNH India supplies Metotrexato Semanal Cipla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Cipla Europe Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methotrexate is used in several disease categories where it interferes with abnormal cell proliferation and immune activation.

  • Rheumatoid arthritis: reduces joint inflammation and slows structural damage.
  • Psoriasis: improves skin lesions and decreases disease severity.
  • Acute lymphoblastic leukemia: inhibits malignant lymphoblast proliferation as part of chemotherapy regimens.
  • Non‑Hodgkin lymphoma: contributes to tumor control in combination therapy.

How It Works

  • Methotrexate inhibits the enzyme dihydrofolate reductase, preventing the reduction of dihydrofolic acid to tetrahydrofolate. This blockade disrupts folate‑dependent synthesis of purines and thymidylate, leading to impaired DNA, RNA and protein synthesis in rapidly dividing cells. The resulting antiproliferative effect modulates immune cell activity and reduces inflammatory cytokine production.

Side Effects

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea or vomiting
  • Fatigue or malaise
  • Mouth sores or oral ulceration
  • Diarrhea or abdominal discomfort
  • Elevated liver enzymes

Serious or Rare Side Effects

  • Bone marrow suppression leading to anemia or infection
  • Severe liver toxicity or fibrosis
  • Pulmonary toxicity, including interstitial pneumonitis
  • Renal impairment or failure
  • Rare skin reactions such as Stevens‑Johnson syndrome

Precautions & Warnings

When prescribing methotrexate, clinicians should observe several safety measures to minimize risks.

  • Monitor liver function: perform baseline and periodic liver enzyme tests.
  • Check blood counts: regular complete blood count to detect marrow suppression.
  • Avoid alcohol: limit intake to reduce hepatic toxicity.
  • Use folic acid supplementation: prescribe folic acid to lessen mucosal and hematologic side effects.
  • Contraindicated in pregnancy: do not use in women who are pregnant or may become pregnant.
  • Store below 25°C: keep tablets in the original container, protect from moisture and heat.

Avoid Interactions

Methotrexate interacts with several medicines that can alter its effectiveness or increase toxicity.

Major Interactions (Avoid)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal and renal toxicity.
  • Penicillins and other antibiotics: may enhance bone marrow suppression.
  • Live vaccines: immunosuppression can lead to severe infection.

Moderate Interactions (Monitor Closely)

  • Proton pump inhibitors: may affect methotrexate clearance.
  • Sulfonamide antibiotics: can increase plasma levels of methotrexate.
  • Vitamin supplements containing folic acid (high dose): may reduce therapeutic efficacy.
  • Anticonvulsants (e.g., phenytoin): may lower methotrexate concentrations.

Frequently Asked Questions

Metotrexato Semanal Cipla, containing methotrexate, is prescribed for rheumatoid arthritis, severe plaque psoriasis, acute lymphoblastic leukemia, and non‑Hodgkin lymphoma. In each case the drug works to slow disease progression, reduce inflammation, or inhibit malignant cell growth as part of a broader therapeutic plan.

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folic acid into its active form. This interruption hampers the synthesis of nucleotides needed for DNA, RNA and protein production, thereby limiting the proliferation of rapidly dividing immune cells and cancer cells.

The exact dose of Metotrexato Semanal Cipla is set by the prescribing clinician based on the patient’s diagnosis, disease severity, weight, renal and hepatic function, and response to therapy. Dosage adjustments are made during treatment to balance efficacy with safety.

Methotrexate is classified as pregnancy category X, meaning it is contraindicated in pregnancy because it can cause fetal malformations and loss. It is also not recommended while breastfeeding, as it may be excreted in milk and affect the infant.

To order Metotrexato Semanal Cipla, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methotrexate is often considered the first‑line DMARD because of its proven efficacy, oral administration, and relatively low cost compared with biologic agents. While biologics target specific cytokines, methotrexate has a broader immunosuppressive effect and may be combined with other DMARDs for enhanced control.

Metotrexato Semanal Cipla tablets should be stored below 25 °C in their original packaging. Keep them away from moisture, direct sunlight and heat sources. Do not store in the bathroom or near a kitchen sink where humidity is high.

The product is supplied as oral tablets taken once weekly, usually on the same day each week. Patients should swallow the tablet whole with water and follow any specific instructions from their healthcare provider regarding timing relative to other medications.

Serious risks include bone‑marrow suppression leading to anemia or infection, severe liver toxicity or fibrosis, pulmonary toxicity such as interstitial pneumonitis, and renal impairment. Prompt monitoring of blood counts, liver enzymes and kidney function is essential to detect these complications early.

Methotrexate should be avoided in pregnant women, women planning pregnancy, and individuals with severe liver disease, uncontrolled renal impairment, or known hypersensitivity to the drug. It is also contraindicated in patients receiving live vaccines due to the risk of infection.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methotrexate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT